Reliability of the Modified Frenchay Scale for the Assessment of Upper Limb Function in Adults With Hemiparesis

Laclergue, Zoé; Ghédira, Mouna; Gault-Colas, Caroline; Billy, Laurène; Baude, Mathilde

doi:10.1016/j.apmr.2023.04.003

Cited by 5 publications

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Each task is evaluated from 0 (no movement) to 10 (normal movement). The patient is encouraged to practice stretching for the hyperactive muscles or spastic muscles of the tested upper limb between the two activities, in order to reduce transitory spastic dystonia and spastic contraction in order to be able to carry out the test [25]. The MFS is available on a public site together with some demonstrative videos [26].…”

Section: Evaluation Scalesmentioning

confidence: 99%

Management of Upper-Limb Spasticity Using Modern Rehabilitation Techniques versus Botulinum Toxin Injections Following Stroke

Bumbea,

Rogoveanu,

Turcu-Stiolica

et al. 2023

Life

View full text Add to dashboard Cite

Our purpose is to emphasize the role of botulinum toxin in spasticity therapy and functional recovery in patients following strokes. Our retrospective study compared two groups, namely ischemic and hemorrhagic stroke patients. The study group (BT group) comprised 80 patients who received focal botulinum toxin as therapy for an upper limb with spastic muscle three times every three months. The control group (ES group) comprised 80 patients who received only medical rehabilitation consisting of electrostimulation and radial shockwave therapy for the upper limb, which was applied three times every three months. Both groups received the same stretching program for spastic muscles as a home training program. We evaluated the evolution of the patients using muscle strength, Ashworth, Tardieu, Frenchay, and Barthel scales. The analysis indicated a statistically significant difference between the two groups for all scales, with better results for the BT group (p < 0.0001 for all scales). In our study, the age at disease onset was an important prediction factor for better recovery in both groups but not in all scales. Better recovery was obtained for younger patients (in the BT group, MRC scale: rho = −0.609, p-value < 0.0001; Tardieu scale: rho = −0.365, p-value = 0.001; in the ES group, MRC scale: rho = −0.445, p-value < 0.0001; Barthel scale: rho = −0.239, p-value = 0.033). Our results demonstrated the effectiveness of botulinum toxin therapy compared with the rehabilitation method, showing a reduction of the recovery time of the upper limb, as well as an improvement of functionality and a reduction of disability. Although all patients followed a specific kinetic program, important improvements were evident in the botulinum toxin group.

show abstract

Section: Evaluation Scalesmentioning

confidence: 99%

Management of Upper-Limb Spasticity Using Modern Rehabilitation Techniques versus Botulinum Toxin Injections Following Stroke

Bumbea,

Rogoveanu,

Turcu-Stiolica

et al. 2023

Life

View full text Add to dashboard Cite

show abstract

The Effect of Sensory Therapy on Upper Extremity Functions and Activities of Daily Living in Patients with Chronic Stroke: A Randomized Controlled Trial

Yazıcı,

Cekmece

2024

Preprint

View full text Add to dashboard Cite

Introduction: The aim of this study was to investigate the effects of intensive sensory therapy on upper extremity functions, daily activity and life quality of stroke survivors. Methods: This randomized controlled trial included 30 participants aged between 18 and 80 years, who were divided into a sensory-training group (n = 15) and a control group (n = 15). Both groups received 15 sessions of 30 minutes of physical therapy, occupational therapy, and 20 minutes of activity daily living training for three weeks. The ST group also received intensified sensory therapy during each session. Thumb localization, finger shift, and stereognosis tests were performed in both groups only before the start of intervention. The Jebsen Taylor Hand Function Test, Canadian Occupational Performance Measure, Modified Frenchay Scale, and Stroke Specific Quality of Life Scale (SS-QOL) were administered before and after intervention. Results: Statistically significant differences were observed between the ST group and the control group across all tests, except for the Language, Thinking, and Vision parameters of the SS-QOL. Conclusion: These results suggest that sensory therapies applied with conventional interventions increased upper extremity functions, activity daily living performance, participation and quality of life of the stroke survivors. Registration: URL: https://clinicaltrials.gov/study/NCTxxxxxx Unique identifier: NCTxxxxx.

show abstract

Validity and reliability of the chronic composite XA, an upper limb motor assessment using Active Range of Motion in patients with chronic stroke

JAMAL,

BUTET,

MAITRE

et al. 2024

Eur J Phys Rehabil Med

View full text Add to dashboard Cite

BACKGROUND Upper limb (UL) spastic paresis has been classically evaluated with assessments of passive movements with limited functional validity. The aim of this study was to assess whether a composite measure of active range of motion (AROM, or X A ) is valid and reliable in chronic post-stroke spastic paresis. AIM The primary objective was to investigate the validity and reliability of a composite score, comprising multiple X A measurements, to assess UL spastic paresis in patients in chronic stages post-stroke. In addition to this, an exploratory analysis was conducted to identify which muscles should be optimally included in this composite score. DESIGN A psychometric proprieties study. SETTING Physical and Rehabilitation Medicine Department. POPULATION twenty-eight chronic post-stroke participants with spastic paresis. METHODS Composite UL X A measurement in twenty-eight chronic post-stroke participants (age=59±11 years; delay post-stroke=29±37 months) with spastic paresis was repeated twice about 40 days apart in a standardized body position. Concurrent and construct validity was evaluated exploring correlation with the Fugl-Meyer Assessment Upper Extremity (FMA-UE), Action Research Arm Test (ARAT), and grip strength (JAMAR™). Reliability was assessed by calculating intraclass correlation coefficients (ICC). Regarding the exploratory analysis, a linear regression analysis was performed to examine the value of including various muscles. RESULTS Composite X A against the resistance of elbow, wrist and finger flexors showed strong correlation with FMA-UE and ARAT (r=0.88; P<0.001 and r=0.82; P<0.001 respectively) and a weak association with grip strength (r=0.43; P=0.03). Test-retest reliability was excellent (ICC=0.92). However, the most effective regression model also included X A against the resistance of shoulder adductors as well as forearm pronator (adjusted R 2 =0.85; AIC=170). CONCLUSIONS The present study provided satisfactory psychometric data for the upper limb composite active movement (CX A ), derived from the Five Step Assessment. For overall measurement of UL mobility after stroke, we strongly recommend including shoulder and forearm muscles to the score. CLINICAL REHABILITATION IMPACT Composite X A is a valid and reliable measure of upper limb motor function in chronic post-stroke patients and could be used in clinical practice and research.

show abstract

Reliability of the Modified Frenchay Scale for the Assessment of Upper Limb Function in Adults With Hemiparesis

Cited by 5 publications

References 32 publications

Management of Upper-Limb Spasticity Using Modern Rehabilitation Techniques versus Botulinum Toxin Injections Following Stroke

Management of Upper-Limb Spasticity Using Modern Rehabilitation Techniques versus Botulinum Toxin Injections Following Stroke

The Effect of Sensory Therapy on Upper Extremity Functions and Activities of Daily Living in Patients with Chronic Stroke: A Randomized Controlled Trial

Validity and reliability of the chronic composite XA, an upper limb motor assessment using Active Range of Motion in patients with chronic stroke

Contact Info

Product

Resources

About